Libvatrep

N/A

Report date: 2023/07/07 16:31:41
NME

Base Information

Drug NameLibvatrep
Drug Alias NameSAF-312ASAF-312
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily V antagonists
TargetsTransient receptor potential cation channel subfamily V
Therapy Area/IndicationsPain, PostoperativeEye PainUrinary Bladder, Neurogenic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsGermany +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesBausch & LombNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsEye Pain
Inactive IndicationsPain, PostoperativeUrinary Bladder, Neurogenic

Other Information

ATC CodeN/A
Related LinksN/A